TGA approves Pfizer for five to 11-year-olds

The Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer vaccine as safe and effective for use among Australian children aged five to 11-years-old. Subject to final approvals, the Australian Government expects to start rolling out the vaccine to children from January 10 next year. The vaccine dose approved by the TGA for children aged 5 to 11 is the same safe and effective vaccine used for other age cohorts, however is one-third the dose approved for those aged 12 and over. READ MORE: Queensland records seven new COVID-19 infections including one potential Omicron case The government expects to receive ATAGI's recommendations on how to incorporate this safe and effective vaccine into the nation's COVID-19 vaccination program over the coming weeks. Subject to advice from ATAGI, vaccinating the approximately 2.3 million children aged five to 11 in Australia will build on the rapid uptake of vaccination among children aged 12 to 15. In just 11 weeks, more..

The Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer vaccine as safe and effective for use among Australian children aged five to 11-years-old.

Subject to final approvals, the Australian Government expects to start rolling out the vaccine to children from January 10 next year.

The vaccine dose approved by the TGA for children aged 5 to 11 is the same safe and effective vaccine used for other age cohorts, however is one-third the dose approved for those aged 12 and over.

READ MORE: Queensland records seven new COVID-19 infections including one potential Omicron case

The Pfizer vaccine could be approved for children under the age of 12 by Christmas as Australia ramps up efforts to protect more people from COVID-19.

The government expects to receive ATAGI's recommendations on how to incorporate this safe and effective vaccine into the nation's COVID-19 vaccination program over the coming weeks.

Subject to advice from ATAGI, vaccinating the approximately 2.3 million children aged five to 11 in Australia will build on the rapid uptake of vaccination among children aged 12 to 15.

In just 11 weeks, more than 76.6 per cent of this group have had at least one dose of vaccine, with 67.5 per cent having completed their two-dose course of vaccination.

Across the country, 87.9 per cent of Australians aged 16 or over are fully vaccinated. More than 92.8 per cent have had at least one dose of COVID-19 vaccine.

READ MORE: Australian Parliament House closed after positive COVID-19 case

A vaccine for five to 11-year-old children could be available within weeks.

The TGA's provisional approval of the Pfizer vaccine for five to 11-year-olds was based on a careful evaluation of available data to support its safety and efficacy among this age group.

The vaccine dose approved by the TGA for children aged 5 to 11 is the same safe and effective vaccine used for other age cohorts, however is one-third the dose approved for those aged 12 and over.

The Pfizer vaccine for 5 to 11-year-olds will be distributed to vaccine providers in different packaging to the vaccine approved for people 12 and over, and will be clearly differentiated by being dispensed from orange-capped vials instead of grey or purple capped vials.

As with other age groups, the use of this vaccine in children aged 5-11 years should be given in two doses at least 3 weeks apart.

The Australian Government expects to start rolling out the Pfizer vaccine to 5 to 11-year-olds from January 10 next year.

Planning underway

The government said significant planning work has already been undertaken involving the COVID-19 Vaccines Taskforce, the states and territories primary health professionals in relation to how the vaccination rollout will be extended to children in this age group.

It is expected the vaccines would initially be made available through general practices Aboriginal Health Services, community pharmacies and state and territory clinics.

READ MORE: Belgian zoo says its two very runny-nosed hippos have COVID-19

The TGA is also currently evaluating an application from Moderna for its COVID-19 vaccine to be used in Australia for children aged six to 11.

"The Commonwealth government will continue to work closely with vaccine providers and states and territories as a priority to provide the opportunity for children aged 5 to 11 to receive a first dose of this COVID-19 vaccine in the lead up to and in parallel with school returning in 2022," a government spokesperson said.

"The government has an agreement in place with Pfizer to receive sufficient supply of the paediatric vaccine for the entire population of children aged 5 to 11 in Australia.

"The first shipment of children's doses are due to arrive in Australia by early January and will undergo the same rigorous batch testing processes in the TGA laboratories as other batches of COVID-19 vaccines."

The TGA is also currently evaluating an application from Moderna for its COVID-19 vaccine to be used in Australia for children aged six to 11 and the government already has supply deals in place to make it available should it be approved by the TGA and recommended by ATAGI.

This two-step TGA and ATAGI assessment and approval process is the same rigorous process followed for all COVID-19 vaccine approvals in Australia.

Share your love

Leave a Reply